• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miRNA-210 的上调通过靶向寻常型银屑病 CD4+T 细胞中的 FOXP3 诱导免疫功能障碍。

Up-regulation of microRNA-210 induces immune dysfunction via targeting FOXP3 in CD4(+) T cells of psoriasis vulgaris.

机构信息

Department of Dermatology, Second Xiangya Hospital, Central South University, Hunan Key Laboratory of Medical Epigenomics, Changsha, 410011 Hunan, China.

Division of Allergy, Asthma and Immunology, Department of Pediatrics, Thomas Jefferson University Hospital, USA.

出版信息

Clin Immunol. 2014 Jan;150(1):22-30. doi: 10.1016/j.clim.2013.10.009. Epub 2013 Oct 25.

DOI:10.1016/j.clim.2013.10.009
PMID:24316592
Abstract

Psoriasis vulgaris (PV) is a chronic inflammatory and T cell-mediated autoimmune skin disease. An immune dysfunction that is manifested by abnormally activated T cells and defective regulatory T (Treg) cells may play an important role in the pathogenesis of PV. However, the precise mechanism of the immune dysfunction in PV patients still remains unclear. In this study, we found that miR-210 expression is increased significantly in CD4(+) T cells from patients with PV and confirmed that FOXP3 is a target gene of miR-210. We also found that overexpression of miR-210 inhibits FOXP3 expression and impairs the immunosuppressive functions of Treg cells in CD4(+) T cells from healthy controls. In contrast, inhibition of miR-210 increases FOXP3 expression and reverses the immune dysfunction in CD4(+) T cells from patients with PV. Our data demonstrates that increased miR-210 induces immune dysfunction via by FOXP3 in CD4(+) T cells from patients with PV.

摘要

寻常型银屑病(PV)是一种慢性炎症性和 T 细胞介导的自身免疫性皮肤病。免疫功能紊乱,表现为异常激活的 T 细胞和功能缺陷的调节性 T(Treg)细胞,可能在 PV 的发病机制中发挥重要作用。然而,PV 患者免疫功能紊乱的确切机制仍不清楚。在本研究中,我们发现 miR-210 在 PV 患者的 CD4+T 细胞中表达显著增加,并证实 FOXP3 是 miR-210 的靶基因。我们还发现,miR-210 的过表达抑制 FOXP3 的表达,并损害来自健康对照者的 CD4+T 细胞中的 Treg 细胞的免疫抑制功能。相反,抑制 miR-210 增加了 FOXP3 的表达,并逆转了来自 PV 患者的 CD4+T 细胞中的免疫功能紊乱。我们的数据表明,miR-210 的增加通过 FOXP3 在来自 PV 患者的 CD4+T 细胞中诱导免疫功能紊乱。

相似文献

1
Up-regulation of microRNA-210 induces immune dysfunction via targeting FOXP3 in CD4(+) T cells of psoriasis vulgaris.miRNA-210 的上调通过靶向寻常型银屑病 CD4+T 细胞中的 FOXP3 诱导免疫功能障碍。
Clin Immunol. 2014 Jan;150(1):22-30. doi: 10.1016/j.clim.2013.10.009. Epub 2013 Oct 25.
2
MiR-200a expression in CD4+ T cells correlates with the expression of Th17/Treg cells and relevant cytokines in psoriasis vulgaris: A case control study.miR-200a 在 CD4+T 细胞中的表达与寻常型银屑病中 Th17/Treg 细胞及相关细胞因子的表达相关:一项病例对照研究。
Biomed Pharmacother. 2017 Sep;93:1158-1164. doi: 10.1016/j.biopha.2017.06.055.
3
Profiles of Foxp3+ regulatory T cells in eczematous dermatitis, psoriasis vulgaris and mycosis fungoides.湿疹性皮炎、寻常型银屑病和蕈样肉芽肿中Foxp3 +调节性T细胞的特征
Br J Dermatol. 2008 Jun;158(6):1256-63. doi: 10.1111/j.1365-2133.2008.08504.x. Epub 2008 Mar 20.
4
Circulating CD4+CD25 bright FOXP3+ T cells are up-regulated by biological therapies and correlate with the clinical response in psoriasis patients.循环 CD4+CD25brightFOXP3+T 细胞受生物疗法的调节,并与银屑病患者的临床反应相关。
Dermatology. 2009;219(3):250-8. doi: 10.1159/000238305. Epub 2009 Sep 11.
5
Total glucosides of paeony induces regulatory CD4(+)CD25(+) T cells by increasing Foxp3 demethylation in lupus CD4(+) T cells.白芍总苷通过增加狼疮 CD4+T 细胞中 Foxp3 的去甲基化诱导调节性 CD4+CD25+T 细胞。
Clin Immunol. 2012 May;143(2):180-7. doi: 10.1016/j.clim.2012.02.002. Epub 2012 Feb 16.
6
Balance of Treg vs. T-helper cells in the transition from symptomless to lesional psoriatic skin.调节性 T 细胞与辅助性 T 细胞在无症状至皮损性银屑病皮肤转变中的平衡。
Br J Dermatol. 2013 Jun;168(6):1294-302. doi: 10.1111/bjd.12236.
7
Disruption of circulating CD4+ T-lymphocyte subpopulations in psoriasis patients is ameliorated by narrow-band UVB therapy.窄谱中波紫外线疗法可改善银屑病患者循环CD4 + T淋巴细胞亚群的紊乱。
Cell Biochem Biophys. 2015 Jan;71(1):499-507. doi: 10.1007/s12013-014-0230-z.
8
Deregulation of circ_003912 contributes to pathogenesis of erosive oral lichen planus by via sponging microRNA-123, -647 and -31 and upregulating FOXP3.环状非编码 RNA_003912 的失调通过海绵吸附 microRNA-123、-647 和 -31 并上调 FOXP3 促进糜烂性口腔扁平苔藓的发病机制。
Mol Med. 2021 Oct 20;27(1):132. doi: 10.1186/s10020-021-00382-4.
9
MicroRNA-138 regulates the balance of Th1/Th2 via targeting RUNX3 in psoriasis.微小RNA-138通过靶向RUNX3调控银屑病中Th1/Th2的平衡。
Immunol Lett. 2015 Jul;166(1):55-62. doi: 10.1016/j.imlet.2015.05.014. Epub 2015 Jun 1.
10
Human natural Treg microRNA signature: role of microRNA-31 and microRNA-21 in FOXP3 expression.人类天然调节性T细胞的微小RNA特征:微小RNA - 31和微小RNA - 21在叉头框蛋白P3表达中的作用
Eur J Immunol. 2009 Jun;39(6):1608-18. doi: 10.1002/eji.200838509.

引用本文的文献

1
Tissue-specific roles of regulatory T cells: mechanisms of suppression and beyond along with emerging therapeutic insights in autoimmune indications.调节性T细胞的组织特异性作用:抑制机制及其他,以及自身免疫性疾病中新兴的治疗见解
Front Immunol. 2025 Aug 26;16:1650451. doi: 10.3389/fimmu.2025.1650451. eCollection 2025.
2
Oral and topical vitamin D treatment strategies in psoriasis.银屑病的口服及外用维生素D治疗策略
Skin Health Dis. 2025 Apr 22;5(3):178-190. doi: 10.1093/skinhd/vzaf010. eCollection 2025 Jun.
3
Psoriasis Treatments: Emerging Roles and Future Prospects of MicroRNAs.
银屑病治疗:微小RNA的新作用与未来前景
Noncoding RNA. 2025 Feb 13;11(1):16. doi: 10.3390/ncrna11010016.
4
miRNA: The Next Frontier in Dermatology Research and Therapeutics.微小RNA:皮肤病学研究与治疗的新前沿
Indian J Dermatol. 2024 Nov-Dec;69(6):486. doi: 10.4103/ijd.ijd_568_23. Epub 2024 Oct 29.
5
Emerging insights into the role of natural products and miRNAs in psoriasis: from pathophysiology to precision medicine.天然产物和微小RNA在银屑病中的作用新见解:从病理生理学到精准医学
Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar;398(3):2487-2509. doi: 10.1007/s00210-024-03528-3. Epub 2024 Oct 28.
6
Promising strategies in natural products treatments of psoriasis-update.天然产物治疗银屑病的前沿策略——最新进展
Front Med (Lausanne). 2024 Sep 4;11:1386783. doi: 10.3389/fmed.2024.1386783. eCollection 2024.
7
NETosis of psoriasis: a critical step in amplifying the inflammatory response.银屑病的 NETosis:放大炎症反应的关键步骤。
Front Immunol. 2024 Aug 1;15:1374934. doi: 10.3389/fimmu.2024.1374934. eCollection 2024.
8
Molecular Morbidity Score-Can MicroRNAs Assess the Burden of Disease?分子发病评分——微小 RNA 可评估疾病负担吗?
Int J Mol Sci. 2024 Jul 24;25(15):8042. doi: 10.3390/ijms25158042.
9
Is Mir-205 a possible biomarker for evaluating treatment response in psoriasis?miR-205 是否可作为评估银屑病治疗应答的生物标志物?
J Med Life. 2024 Mar;17(3):353-359. doi: 10.25122/jml-2024-0264.
10
A Review of MicroRNAs and lncRNAs in Atherosclerosis as Well as Some Major Inflammatory Conditions Affecting Atherosclerosis.微小RNA和长链非编码RNA在动脉粥样硬化以及影响动脉粥样硬化的一些主要炎症性疾病中的研究综述
Biomedicines. 2024 Jun 13;12(6):1322. doi: 10.3390/biomedicines12061322.